Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Insmed, Inc.
Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases.
IPO Date: June 1, 2000
Sector: Healthcare
Industry: Biotech
Market Cap: $19.3B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.40 | 2.85%
Avg Daily Range (30 D): $1.47 | 1.91%
Avg Daily Range (90 D): $1.52 | 2.02%
Institutional Daily Volume
Avg Daily Volume: .78M
Avg Daily Volume (30 D): 3.05M
Avg Daily Volume (90 D): 2.25M
Trade Size
Avg Trade Size (Sh.): 137
Avg Trade Size (Sh.) (30 D): 68
Avg Trade Size (Sh.) (90 D): 68
Institutional Trades
Total Inst.Trades: 8,303
Avg Inst. Trade: $3.04M
Avg Inst. Trade (30 D): $7.42M
Avg Inst. Trade (90 D): $8.25M
Avg Inst. Trade Volume: .08M
Avg Inst. Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $5.64M
Avg Closing Trade (30 D): $30.46M
Avg Closing Trade (90 D): $23.93M
Avg Closing Volume: 158.41K
   
News
Jun 20, 2025 @ 5:37 PM
Russell Rebalance: 3 Stocks Ready to Move Higher
Source: Marketbeat.Com
Jun 11, 2025 @ 5:32 PM
Insmed's Pulmonary Hypertension Drug Data Exceeded...
Source: Vandana Singh
May 23, 2025 @ 8:49 AM
8MM Bronchiectasis Market Opportunity Assessment a...
Source: Researchandmarkets.Com
Jan 21, 2025 @ 6:00 PM
Bronchiectasis Market to Show Positive Growth at a...
Source: Delveinsight
Jan 14, 2025 @ 6:00 PM
Evolving Landscape of Cardiology Segment: Key Mark...
Source: Delveinsight
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-5.93 $-1.42 $-1.3
Diluted EPS $-5.93 $-1.42 $-1.3
Revenue $ 381.03M $ 92.82M $ 104.44M
Gross Profit $ 291.47M $ 71.55M $ 78.29M
Net Income / Loss $ -1013.26M $ -256.58M $ -235.55M
Operating Income / Loss $ -980.89M $ -248.14M $ -230.41M
Cost of Revenue $ 89.56M $ 21.28M $ 26.15M
Net Cash Flow $ -192.48M $ -151.78M $ 93.58M
PE Ratio    
Splits
Mar 03, 2011:   1:10
Jul 31, 2000:   1:4